Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab

被引：0
|
作者：
Jessica R. Allegretti
Edward L. Barnes
Betsey Stevens
Margaret Storm
Ashwin Ananthakrishnan
Vijay Yajnik
Joshua Korzenik
机构：
[1] Brigham and Women’s Hospital,Division of Gastroenterology
[2] Massachusetts General Hospital,Gastroenterology Unit
[3] Harvard Medical School,undefined
来源：
Digestive Diseases and Sciences | 2017年 / 62卷
关键词：
Vedolizumab; Combination therapy; Immunomodulator; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1590 / 1596
页数：6
相关论文
共 50 条
  • [21] Postoperative outcomes in vedolizumab-treated pediatric patients undergoing abdominal operations for inflammatory bowel disease
    Lightner, Amy L.
    Tse, Chung Sang
    Potter, D. Dean, Jr.
    Moir, Christopher
    JOURNAL OF PEDIATRIC SURGERY, 2018, 53 (09) : 1706 - 1709
  • [22] Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experience
    Ibraheim, Hajir
    Samaan, Mark A.
    Srinivasan, Ashish
    Brain, Oliver
    Digby-Bell, Jonathan
    Irving, Peter M.
    Norman, Irena
    Jawad, Issrah
    Biedermann, Julia
    Ibarra, Ana
    Kok, Klaartje Bel
    Parkes, Gareth
    Rimmer, Joanna
    Compot, Elisabeta
    Parkes, Miles
    Segal, Jonathan
    Oppong, Philip
    Hart, Ailsa
    Hayee, Bu'Hussain
    Powell, Nick
    ANNALS OF GASTROENTEROLOGY, 2020, 33 (02): : 170 - +
  • [23] Malnutrition and sarcopenia are prevalent among inflammatory bowel disease patients with clinical remission
    Unal, Nalan Gulsen
    Oruc, Nevin
    Tomey, Oksan
    Ömer Özutemiz, Ahmet
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (11) : 1367 - 1375
  • [24] Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease
    Dubinsky, Marla C.
    Cross, Raymond K.
    Sandborn, William J.
    Long, Millie
    Song, Xue
    Shi, Nianwen
    Ding, Yao
    Eichner, Samantha
    Pappalardo, Brandee
    Ganguli, Arijit
    Wang, Anthony
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (09) : 1876 - 1882
  • [25] Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials
    Feagan, Brian G.
    Bhayat, Fatima
    Khalid, Mona
    Blake, Aimee
    Travis, Simon P. L.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (08) : 905 - 919
  • [26] Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study
    Caron, Benedicte
    Peyrin-Biroulet, Laurent
    Pariente, Benjamin
    Bouhnik, Yoram
    Seksik, Philippe
    Bouguen, Guillaume
    Caillo, Ludovic
    Laharie, David
    Carbonnel, Franck
    Altwegg, Romain
    Reenaers, Catherine
    Serrero, Melanie
    Trang-Poisson, Caroline
    Nancey, Stephane
    Filippi, Jerome
    Abitbol, Vered
    Savoye, Guillaume
    Vuitton, Lucine
    Viennot, Stephanie
    Fumery, Mathurin
    Reymond, Maud
    Bronowicki, Jean-Pierre
    Reimund, Jean-Marie
    Amiot, Aurelien
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (10) : 1239 - 1247
  • [27] Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases
    Coletta, Marina
    Paroni, Moira
    Alvisi, Maria Francesca
    De Luca, Matilde
    Rulli, Eliana
    Mazza, Stefano
    Facciotti, Federica
    Lattanzi, Georgia
    Strati, Francesco
    Abrignani, Sergio
    Fantini, Massimo Claudio
    Vecchi, Maurizio
    Geginat, Jens
    Caprioli, Flavio
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (09) : 1190 - 1201
  • [28] Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
    Poylin, Vitaliy Y.
    Serrato, Jose Cataneo
    Del Valle, Jonathan Pastrana
    Feuerstein, Joseph D.
    INTESTINAL RESEARCH, 2022, 20 (01) : 72 - 77
  • [29] Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease
    Hanzel, Jurij
    Sever, Nejc
    Ferkolj, Ivan
    Stabuc, Borut
    Smrekar, Natasa
    Kurent, Tina
    Kozelj, Matic
    Novak, Gregor
    Compernolle, Griet
    Tops, Sophie
    Gils, Ann
    Drobne, David
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (06) : 741 - 749
  • [30] Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study
    Amiot, Aurelien
    Serrero, Melanie
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Vuitton, Lucine
    Viennot, Stephanie
    Bouguen, Guillaume
    Abitbol, Vered
    Fumery, Mathurin
    Gagniere, Charlotte
    Bouhnik, Yoram
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (01) : 40 - 53
12345